Number of Nevada Medical Marijuana Users is Growing

Nevada’s medical marijuana program is growing, gaining nearly 12,000 new patients in 2016, but the total number of patients is less than 10% of the total population. With is considerably less than the percentage of users of hydrocodone and other opioids.

As a result Nevada’s MMJ business is struggling, but dispensaries are hoping for a change when recreational legalization is implemented in 2018.

Nevada Leaked Every MMJ Applicant’s Personal Data

From CBS:
“Nevada’s state government website has leaked the personal data on over 11,700 applicants for dispensing medical marijuana in the state.

Each application, eight pages in length, includes the person’s full name, home address, citizenship, and even their weight and height, race, and eye and hair color. The applications also include the applicant’s citizenship, their driving license number (where applicable), and social security number.”

A spokesperson for the Nevada Dept. Health and Human Services, which runs the medical marijuana application program, told ZDNet that the website has been pulled offline to limit the vulnerability. They added that the leaked data was a “portion” of one of several databases.

The Officials of the state of Nevada will be notifying applicants in the next few days, as mandated by state law.

Study Shows Cannabis May Be Used to Treat Diabetes.

Cannabis
Activation of the cannabinoid 2 receptor may be a potential treatment option for insulin resistance and obesity-related diabetes.

This according to new research at the Institute of Biomedical Engineering at the Chinese Academy of Medical Science, the was study was first published in the Journal of Cellular Physiology and Biochemistry.

The endocannabinoid signalling (ECS) system has been known to regulate glucose homeostasis. Previous studies have suggested that the cannabinoid 2 (CB2) receptor may play a regulatory role on insulin secretion, immune modulation and insulin resistance. Given that diabetes and insulin resistance are attributable to elevated inflammatory tone, we investigated the role of CB2 receptor on glucose tolerance and insulin sensitivity in high-fat diet (HFD)/streptozotocin (STZ)-induced mice.

In other words smoking dope may actually be good for you.

A Framework for the Legalization and Regulation of Cannabis in Canada.

The Canadian task force on Cannabis Legalization and Regulation has released “A Framework for the Legalization and Regulation of Cannabis in Canada.”

It only took five months, which by government standards is light speed. They covered everything from advertising and taxation to growing marijuana and processing concentrates.

Here’s the index:

Table of Contents

Foreword
Executive Summary
Chapter 1: Introduction
Our mandate
The Canadian context
A global perspective
Setting the frame
Public policy objectives
Engagement process
Guiding principles
Chapter 2: Minimizing Harms of Use
Introduction: a public health approach
Minimum age
Promotion, advertising and marketing restrictions
Cannabis-based edibles and other products
THC potency
Tax and price
Public education
Prevention and treatment
Workplace safety
Chapter 3: Establishing a Safe and Responsible Supply Chain
Introduction
Production
Distribution
Retail
Personal cultivation
Chapter 4: Enforcing Public Safety and Protection
Introduction
Illegal activities
Personal possession
Place of use
Impaired driving
Chapter 5: Medical Access
Introduction
One system or two?
Access
Affordability
Products
Public safety
Evidence and research
Chapter 6: Implementation
Capacity
Oversight
Co-ordination
Communication
Annex 1: Biographies of Task Force on Cannabis Legalization and Regulation Members
Annex 2: Terms of Reference
Annex 3: Acknowledgements
Annex 4: Discussion Paper ‘Toward the Legalization, Regulation and Restriction of Access to Marijuana’
Annex 5: Executive Summary: Analysis of consultation input submitted to the Task Force on Cannabis Legalization and Regulation

You read that right. It really is 6 chapters and 5 annexes.

Talk about dotting your Is and crossing your Ts.

DEA Easing Restrictions on Marijuana Testing for PTSD

Well the DEA has finally started easing restrictions on testing marijuana as a treatment for PTSD. It’s only taken one doctor 5 years to wade through the paperwork / bureaucratic nightmare.

Dr. Sisley, a psychiatrist and former clinical assistant professor at the University of Arizona College of Medicine, has been fighting to carry out the study since 2011, when it was first approved by the U.S. Food and Drug Administration.

First: The federal government categorizes marijuana as a Schedule 1 drug, the most restrictive of five groups.

Second: The only approved cannabis source is the University of Mississippi.

Next: Researchers like Dr. Sisley must apply to the Food and Drug Administration, the Drug Enforcement Administration and the National Institute on Drug Abuse

And to top it off participants will need to be veterans diagnosed with PTSD who have found their condition resistant to conventional treatments. (40 in Phoenix and 40 in Baltimore)

My hat’s off to the good doctor because you really have to be dedicated jump through that many hoops.